More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.

A Medicaid policy change left fewer kids with access to an asthma inhaler Children were more likely to have no asthma inhaler after GlaxoSmithKline withdrew Flovent from the market GSK withdrew ...

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. The pharma company continued to sell a chemically ...

GSK withdrew the inhaler after a policy change exposed the company to higher Medicaid rebate costs WEDNESDAY, April 30, 2025 (HealthDay News) — More children stopped using steroid inhalers to ...

Please provide your email address to receive an email when new articles are posted on . “While antibiotics are assuredly useful and important drugs, this study underscores potential long-term ...

GSK withdrew the inhaler after a policy change exposed the company to higher Medicaid rebate costs WEDNESDAY, April 30, 2025 (HealthDay News) — More children stopped using steroid inhalers to control ...